Trial Profile
A Pilot Study of Systemically Administered Bevacizumab in Patients With Neoplastic Meningitis (NM)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Neoplastic meningitis
- Focus Therapeutic Use
- 10 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Nov 2013 Planned end date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 26 Nov 2012 Planned End Date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.